Shares of Milestone Scientific Inc. (NYSEAMERICAN:MLSS) were down 2.9% during trading on Tuesday . The stock traded as low as $0.34 and last traded at $0.33. Approximately 2,159 shares traded hands during trading, a decline of 99% from the average daily volume of 223,025 shares. The stock had previously closed at $0.34.
Milestone Scientific (NYSEAMERICAN:MLSS) last announced its quarterly earnings data on Monday, April 1st. The medical instruments supplier reported $0.01 EPS for the quarter. The firm had revenue of $3.77 million for the quarter.
An institutional investor recently bought a new position in Milestone Scientific stock. Mercer Global Advisors Inc. ADV purchased a new stake in Milestone Scientific Inc. (NYSEAMERICAN:MLSS) during the first quarter, according to its most recent filing with the SEC. The fund purchased 117,750 shares of the medical instruments supplier’s stock, valued at approximately $39,000. Mercer Global Advisors Inc. ADV owned about 0.29% of Milestone Scientific as of its most recent filing with the SEC.
Milestone Scientific Company Profile (NYSEAMERICAN:MLSS)
Milestone Scientific, Inc develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances.
Read More: What does relative strength index mean?
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.